Interest is growing in synthetic securitisations backed by trade finance receivables - collateral that is particularly suited to the synthetic structure. These transactions exhibit several differences to corporate capital relief trades and while some of these can cause certain challenges, they also offer issuers and investors unique benefits.
Peter Wong, md, portfolio management at Standard Chartered, says that the synthetic trade finance securitisation market has been growing steadily in recent years, with a healthy pipeline and good investor appetite for deals.
Not yet registered? Join today to access SCI Content.